| Trial ID: | L3718 |
| Source ID: | NCT01459601
|
| Associated Drug: |
Cabergoline
|
| Title: |
Cabergoline Effect on Blood Sugar in Type 2 Diabetics
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2
|
| Interventions: |
DRUG: Cabergoline
|
| Outcome Measures: |
Primary: FBS (fasting blood sugar), 30days | Secondary: HbA1C, 30days
|
| Sponsor/Collaborators: |
Sponsor: Mashhad University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-01
|
| Completion Date: |
2012-02
|
| Results First Posted: |
|
| Last Update Posted: |
2011-10-25
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01459601
|
